MedTrace Logo

Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

NCT05507476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-10-01

No results posted yet for this study

Summary

Dacryocystorhinostomy aims to create a channel between the lacrimal sac and nasal mucosa to relieve nasolacrimal duct occlusion. General anesthesia is still preferred by many surgeons to secure the airway and control blood pressure.

Conditions

  • Anesthesia

Interventions

DRUG

Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray

The patient will receive two puffs of desmopressin acetate 10 µg/puff in the side of the nasal cavity ipsilateral to the obstructed lacrimal duct (20 μg totally) 60 minutes before surgery.

DRUG

Epinephrine topical 1:100,000 Nasal Packs

The patient will receive topical 1:100,000 epinephrine in the side of the nasal cavity ipsilateral to the obstructed lacrimal gland via 3 soaked packs placed in the middle meatus for 5 minutes immediately before the start of surgery.

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Alshaimaa Abdel Fattah Kamel, MD · Assistant professor of Anesthesia, Intensive Care & Pain management,Zagazig University

  • Marwa Ahmed Mohamed Khedr, MD · Lecturer of Ophthalmology, Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05507476 on ClinicalTrials.gov